[引用][C] Role of patient-derived cancer models in translational oncology
M Gomzikova - J Genet Mol Biol, 2023
Turning data into information: Using PD3D® models to guide colorectal cancer therapy by Optim.AITM
U Pfohl, M Mohd Abdul Rashid, JJ Lim, J Loskutov… - Cancer Research, 2024 - AACR
Colorectal cancer (CRC) is one of the most prevalent and lethal malignancies globally with
up to 50% of patients eventually progressing to metastatic disease. The mitogen-activated …
up to 50% of patients eventually progressing to metastatic disease. The mitogen-activated …
Abstract P3-11-15: Development of pan-cancer transcriptional signatures that predict chemosensitivity
JD Wells, TW Miller - Cancer Research, 2019 - AACR
Background: Despite the increasing understanding of the molecular characteristics of
cancer, chemotherapy success rates remain low for many cancer types. Studies have …
cancer, chemotherapy success rates remain low for many cancer types. Studies have …
[PDF][PDF] MODELLING AND SURVIVAL PREDICTION IN CANCER
AS Halkola - utupub.fi
Cancer is one of the leading causes of death, thus opening a vast need for extensive
research and insights. The survival prospects, along with treatment benefits and costs …
research and insights. The survival prospects, along with treatment benefits and costs …
Using organoid models to predict chemotherapy efficacy: the future of precision oncology?
Introduction: Cancer related causes of death remain a global health issue in both
developing and developed countries. Traditionally, therapies have been utilized to …
developing and developed countries. Traditionally, therapies have been utilized to …
Deep transfer learning for drug response prediction
H Sharifi Noghabi - 2021 - summit.sfu.ca
The goal of precision oncology is to make accurate predictions for cancer patients via some
omics data types of individual patients. Major challenges of computational methods for drug …
omics data types of individual patients. Major challenges of computational methods for drug …
Personalized cancer therapy using a patient-derived tumor tissue xenograft model: a translational field worthy of exploring further?
K Jin, K He, G Li, L Teng - Personalized Medicine, 2010 - Taylor & Francis
It has long been observed that interpatient variability in response to anticancer drugs is
associated with different outcomes. Oncologists continually hold the desire of matching the …
associated with different outcomes. Oncologists continually hold the desire of matching the …
New tools for cancer chemotherapy: computational assistance for tailoring treatments
SN Gardner, M Fernandes - Molecular Cancer Therapeutics, 2003 - AACR
Computational models of cancer chemotherapy have the potential to streamline clinical trial
design, contribute to the design of rational, tailored treatments, and facilitate our …
design, contribute to the design of rational, tailored treatments, and facilitate our …
Machine learning and data mining frameworks for predicting drug response in cancer: An overview and a novel in silico screening process based on association rule …
A major challenge in cancer treatment is predicting the clinical response to anti-cancer
drugs on a personalized basis. The success of such a task largely depends on the ability to …
drugs on a personalized basis. The success of such a task largely depends on the ability to …
NeuPD—A neural network-based approach to predict antineoplastic drug response
With the beginning of the high-throughput screening, in silico-based drug response analysis
has opened lots of research avenues in the field of personalized medicine. For a decade …
has opened lots of research avenues in the field of personalized medicine. For a decade …